86639-48-7Relevant articles and documents
A hydroxy camptothecin preparation method (by machine translation)
-
Paragraph 0026-0027, (2018/11/22)
The invention belongs to the technical field of synthetic drugs, in particular to a hydroxy camptothecin preparation method, acid solvent to dissolve camptothecin adding oxidant sodium perborate, constant temperature after the reaction of the pressure of the reaction liquid, by adding ice water to be crystal is completely after precipitation, filtration, washing, drying to obtain the 1 - oxygen camptothecin; 1 - oxygen camptothecin added dioxane, acetonitrile, water and concentrated sulfuric acid is dissolved and stirring, ultraviolet high-pressure mercury lamp illumination, ice water the reflux condensation; pressure reducing concentrated, adding ice water to be crystal is completely after precipitation, filtering, washing, drying to obtain the crude product; crude purification. The operation of the invention is simple, safe and economic, environmental protection, high total yield. (by machine translation)
Chemical modification of an antitumor alkaloid camptothecin: Synthesis and antitumor activity of 7-C-substituted camptothecins
Sawada,Nokata,Furuta,Yokokura,Miyasaka
, p. 2574 - 2580 (2007/10/02)
A radical substitution reaction of 20(S)-camptothecin (1) with methanol furnished 7-hydroxymethylcamptothecin (2). Reaction of 1 with primary alcohols higher than methanol gave 7-alkylcamptothecins (4), of which alkyl groups were one carbon less than the alcohols used and also 7-hydroxyalkylcamptothecins (5). For the preparation of 7-alkylcamptothecin (4), aldehydes were used as a radical source and several alkylated derivatives were synthesized. 7-Acyloxymethyl derivatives (6), 7-carbaldehyde (7), iminomethyl derivatives (10), acid (11), esters (12) and amides (13) were synthesized starting from 2. 7-Ethyl- (4b) and 7-propylcamptothecin (4c), acyloxymethyl compounds 6a, 6c and ethyl ester (12b) exhibited higher antitumor activity than 1 against L1210 in mice.
Camptothecin derivatives and process for preparing same
-
, (2008/06/13)
New Camptothecin derivatives possessing high anti-tumor activity with slight toxicity, represented by the general formula: STR1 wherein R1 is a hydrogen atom, an alkyl group, a hydroxyl group, an alkoxy group or an acyloxy group, R2 for a hydrogen atom, an alkyl group, an aralkyl group, a hydroxymethyl group, a carboxymethyl group or an acyloxymethyl group, and R3 is the grouping --XR' (where R' is a hydrogen atom, an alkyl group or an acyl group and X is an oxygen atom or a sulfur atom), a nitro group, an amino group, an alkylamino group, an acylamino group or a halogen atom, with the proviso that when both of R1 and R2 are hydrogen atoms, R3 should not be a hydroxyl group, methoxy group or acetoxy group. These new camptothecin derivatives are prepared by treating a 5-R1 -7-R2 -camptothecin derivative with a peroxidant and then reacting the resultant 5-R1 -7-R2 -camptothecin-1-oxide with an active hydrogen compound under irradiation of UV-rays or by catalytically hydrogenating the ring B of camptothecin in a solvent, treating the resultant tetrahydro product with an acylating agent, introducing a nitro group into the 10-position of the acylated product by the reaction with nitric acid, splitting off the acyl group in the 10-nitro product by hydrolysis and treating the hydrolyzed tetrahydro product with an oxidizing agent for dehydrogenation, and if desired, reducing the nitro group in the resulting product to an amino group and modifying the amino group by N-alkylation, N-acylation or by diazotization followed by hydrolysis or the Sandmeyer reaction, before or after the oxidation of the 10-nitro-tetrahydro product.
